Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
NORGES BANK AMH American Homes 4 Rent 13G/A 6.44% 2y
Armon Dadgar HCP HashiCorp, Inc. Class A Common Stock 13G/A 13.7% 2y
Karpus Management, Inc. AQUC Aquaron Acquisition Corp. 13G 5.41% 2y
Karpus Management, Inc. NBXG Neuberger Next Generation Connectivity Fund Inc. 13G 5.1% 2y
Matthew O'Hayer VITL Vital Farms, Inc. 13G/A 23.4% 2y
Karpus Management, Inc. LIBY Liberty Resources Acquisition Corp. Class A Common Stock 13G 5.28% 2y
PRINCIPAL GLOBAL INVESTORS, LLC KMX Carmax Inc 13G/A 5.9% 2y
Estabrook Capital Management FRPH Frp Holdings, Inc. 13G 5% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC INVX Innovex International, Inc. 13G/A 0% 2y
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC BRY Berry Corporation (bry) Common Stock 13G/A 10.5% 2y
SLG SPAC Fund LLC SPKLF Spark I Acquisition Corp 13G 33.93% 2y
Chen Xuezheng GDHG Golden Heaven Group Holdings Ltd. 13G 24% 2y
SUVRETTA CAPITAL MANAGEMENT, LLC BNTC Benitec Biopharma Inc. 13G/A 9.99% 2y
Longitude Capital Partners IV, LLC LXEO Lexeo Therapeutics, Inc. 13G 9.6% 2y
Boston Partners REZI Resideo Technologies, Inc. 13G/A 4.43% 2y
Dodge & Cox FMS Fresenius Medical Care AG 13G/A 7.4% 2y
First Savings Bank Profit Sharing/401(k) Plan FSFG First Savings Financial Group, Inc 13G/A 6.2% 2y
Polar Asset Management Partners Inc. PGSS Pegasus Digital Mobility Acquisition Corp. 13G/A 0% 2y
Mizuho Financial Group, Inc. INTE Integral Acquisition Corporation 1 Class A Common Stock 13G 6.02% 2y
JANUS HENDERSON GROUP PLC EGRX Eagle Pharmaceuticals, Inc. 13G/A 6% 2y
JANUS HENDERSON GROUP PLC MDGL Madrigal Pharmaceuticals, Inc. 13G/A 14.7% 2y
Amova Asset Management Americas, Inc. PD PagerDuty, Inc. 13G/A 4.75% 2y
ALKEON CAPITAL MANAGEMENT LLC AKRO Akero Therapeutics, Inc. Common Stock 13G/A 6.8% 2y
ATW SPAC MANAGEMENT LLC MAQC Maquia Capital Acquisition Corporation Class A Common Stock 13G/A 1.7% 2y
KEY GROUP HOLDINGS (CAYMAN), LTD. DO Diamond Offshore Drilling, Inc. 13G/A 6.7% 2y
John Raymond Murphy CVKD Cadrenal Therapeutics, Inc. 13G/A 5.49% 2y
MMCAP International Inc. SPC MTRY Monterey Innovation Acquisition Corp. Common Stock 13G/A 0% 2y
Steamboat Capital Partners, LLC GPGI GPGI, Inc. 13G/A 12.1% 2y
Dodge & Cox FDX Fedex Corp 13G/A 5.4% 2y
BARROW HANLEY MEWHINNEY & STRAUSS LLC AXTA Axalta Coating Systems Ltd. 13G 6.89% 2y
MSD CAPITAL, L.P. SAFE Safehold Inc. 13G/A 8.5% 2y
Gal Eido RSKD Riskified Ltd. 13G/A 10% 2y
MMCAP International Inc. SPC GRML Greenland Mines Ltd 13G/A 0% 2y
Drew Holdings Ltd. BORR Borr Drilling Ltd 13G 6.2% 2y
CANNELL CAPITAL LLC FTHM Fathom Holdings Inc. 13G/A 7.97% 2y
Institutional Venture Partners XIV, L.P. OPRT Oportun Financial Corp 13G/A 8.5% 2y
Dodge & Cox GSK GSK plc 13G/A 5.8% 2y
BlackRock Inc. RACE Ferrari N.V. 13G/A 5.8% 2y
Logos Global Management LP ANNX Annexon, Inc. 13G/A 8.3% 2y
BB Biotech AG RVMD Revolution Medicines, Inc. 13G/A 3.1% 2y
Lind Global Fund II LP BSFC Blue Star Foods Corp. 13G/A 9.9% 2y
MACKENZIE FINANCIAL CORP CVLT Commvault Systems Inc 13G/A 4.19% 2y
Dodge & Cox VFC V F Corp 13G 8.3% 2y
David A. Steinberg ZETA Zeta Global Holdings Corp. 13G/A 15.2% 2y
Wheaton Precious Metals Corp. HL Hecla Mining Co 13G/A 5.7% 2y
MACKENZIE FINANCIAL CORP AEGXF Aecon Group Inc. 13G/A 0.7% 2y
Champlain Investment Partners, LLC LUNG Pulmonx Corp 13G/A 0% 2y
NewGen Asset Management Ltd ELBM Electra Battery Materials Corp 13G/A 7.6% 2y
BANK OF AMERICA CORP /DE/ EDD Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. 13G/A 5.2% 2y
PRINCIPAL FINANCIAL GROUP INC NFBK Northfield Bancorp, Inc. 13G/A 8.06% 2y